These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 22421701)

  • 1. Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010.
    Martin I; Sawatzky P; Allen V; Hoang L; Lefebvre B; Mina N; Wong T; Gilmour M
    Sex Transm Dis; 2012 Apr; 39(4):316-23. PubMed ID: 22421701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.
    Gianecini R; Romero MLM; Oviedo C; Vacchino M; Galarza P;
    Sex Transm Dis; 2017 Jun; 44(6):351-355. PubMed ID: 28499284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.
    Thakur SD; Starnino S; Horsman GB; Levett PN; Dillon JR
    J Antimicrob Chemother; 2014 Jun; 69(6):1510-6. PubMed ID: 24532681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefixime and ceftriaxone susceptibility of Neisseria gonorrhoeae in Italy from 2006 to 2010.
    Carannante A; Prignano G; Cusini M; Matteelli A; Dal Conte I; Ghisetti V; D'Antuono A; Cavrini F; Antonetti R; Stefanelli P
    Clin Microbiol Infect; 2012 Jun; 18(6):558-64. PubMed ID: 21966997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
    Lindberg R; Fredlund H; Nicholas R; Unemo M
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2117-22. PubMed ID: 17420216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.
    Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M
    J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and molecular characterization of Neisseria gonorrhoeae isolates from Slovenia, 2006-12: rise and fall of the multidrug-resistant NG-MAST genogroup 1407 clone?
    Jeverica S; Golparian D; Matičič M; Potočnik M; Mlakar B; Unemo M
    J Antimicrob Chemother; 2014 Jun; 69(6):1517-25. PubMed ID: 24535277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance and molecular characterisation of Neisseria gonorrhoeae isolates in Fukuoka, Japan, 1996-2016.
    Tanaka M; Furuya R; Kobayashi I; Kanesaka I; Ohno A; Katsuse AK
    J Glob Antimicrob Resist; 2019 Jun; 17():3-7. PubMed ID: 30448519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology of Neisseria gonorrhoeae isolates from Saskatchewan, Canada: utility of NG-MAST in predicting antimicrobial susceptibility regionally.
    Thakur SD; Levett PN; Horsman GB; Dillon JA
    Sex Transm Infect; 2014 Jun; 90(4):297-302. PubMed ID: 24503900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neisseria gonorrhoeae antimicrobial susceptibility in Barcelona: penA, ponA, mtrR, and porB mutations and NG-MAST sequence types associated with decreased susceptibility to cephalosporins.
    Serra-Pladevall J; Barberá MJ; Rodriguez S; Bartolomé-Comas R; Roig G; Juvé R; Andreu A
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1549-56. PubMed ID: 27255221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.
    Unemo M; Golparian D; Nicholas R; Ohnishi M; Gallay A; Sednaoui P
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1273-80. PubMed ID: 22155830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from symptomatic men attending the Nanjing sexually transmitted diseases clinic (2011-2012): genetic characteristics of isolates with reduced sensitivity to ceftriaxone.
    Li S; Su XH; Le WJ; Jiang FX; Wang BX; Rice PA
    BMC Infect Dis; 2014 Nov; 14():622. PubMed ID: 25427572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.
    Lee SG; Lee H; Jeong SH; Yong D; Chung GT; Lee YS; Chong Y; Lee K
    J Antimicrob Chemother; 2010 Apr; 65(4):669-75. PubMed ID: 20093260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing, China.
    Chen SC; Yin YP; Dai XQ; Unemo M; Chen XS
    J Antimicrob Chemother; 2014 Nov; 69(11):2959-65. PubMed ID: 25011655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada.
    Singh AE; Gratrix J; Read R; Lovgren M; Drews SJ; Romanowski B; Sutherland K; Talbot J; Martin I
    Sex Transm Dis; 2013 Sep; 40(9):744-50. PubMed ID: 23945428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.
    Chisholm SA; Alexander S; Desouza-Thomas L; Maclure-Webster E; Anderson J; Nichols T; Lowndes CM; Ison CA;
    J Antimicrob Chemother; 2011 Nov; 66(11):2509-12. PubMed ID: 21846672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibilities and distribution of sequence types of Neisseria gonorrhoeae isolates in Canada: 2010.
    Martin I; Sawatzky P; Liu G; Allen V; Lefebvre B; Hoang L; Lovgren M; Haldane D; Caeseele PV; Horsman G; Garceau R; Ratnam S; Wong T; Gilmour M
    Can J Microbiol; 2013 Oct; 59(10):671-8. PubMed ID: 24102220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftriaxone susceptibility and molecular characteristics of Neisseria gonorrhoeae isolates in Changsha, China.
    Peng T; Lin H; Liu Q; Cao W; Ding H; Chen J; Tang L
    J Infect Chemother; 2017 Jun; 23(6):385-389. PubMed ID: 28446378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000-2009.
    Martin I; Jayaraman G; Wong T; Liu G; Gilmour M;
    Sex Transm Dis; 2011 Oct; 38(10):892-8. PubMed ID: 21934558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.
    Cámara J; Serra J; Ayats J; Bastida T; Carnicer-Pont D; Andreu A; Ardanuy C
    J Antimicrob Chemother; 2012 Aug; 67(8):1858-60. PubMed ID: 22566592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.